Joel Usansky
Impact in
- Ophthalmology top 5%
- Glaucoma and retinal disorders
- Drug-Induced Ocular Toxicity
- Pharmacology top 10%
- Pharmacogenetics and Drug Metabolism
- Inflammatory mediators and NSAID effects
- Cannabis and Cannabinoid Research
Papers in
-
- Pharmacogenetics and Drug Metabolism 3
- Co-authors
- D. Dan-Shya Tang-Liu (2 shared papers)Franklin P. Spriggs (1 shared paper)Julie A. TerWee (1 shared paper)John S. Kenney (1 shared paper)Valerie Theobald (1 shared paper)Adrienne Clements‐Egan (1 shared paper)Afshin Safavi (1 shared paper)Denise M. O’Hara (1 shared paper)
- Journals
- The AAPS Journal (2 papers)Clinical Pharmacology & Therapeutics (1 paper)Bioanalysis (1 paper)Clinical Pharmacokinetics (1 paper)Survey of Ophthalmology (1 paper)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Joel Usansky
11 papers receiving 390 citations
Peers
Comparison fields: 5 of 52
- Ophthalmology 153
- Pharmacology 54
- Immunology 102
- Pharmaceutical Science 35
- Pharmacology 46
Countries citing papers authored by Joel Usansky
This map shows the geographic impact of Joel Usansky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joel Usansky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joel Usansky more than expected).
Fields of papers citing papers by Joel Usansky
This network shows the impact of papers produced by Joel Usansky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joel Usansky. The network helps show where Joel Usansky may publish in the future.
Co-authors
The 25 scholars most cited alongside Joel Usansky, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 189 | |
| 2 | 2012 | 87 | |
| 3 | 1999 | 80 | |
| 4 | 1996 | 41 | |
| 5 | 1994 | 17 | |
| 6 | 1992 | 10 | |
| 7 | 1991 | 9 | |
| 8 | 2021 | 4 | |
| 9 | 1988 | 3 | |
| 10 | 1991 | 2 | |
| 11 | 2012 | 1 |
About Joel Usansky
Joel Usansky is a scholar working on Pharmacology, Ophthalmology, Immunology, Toxicology and Information Systems, having authored 11 papers that have together received 443 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (3 papers), Research Data Management Practices (2 papers), Analytical Methods in Pharmaceuticals (1 paper), Drug Transport and Resistance Mechanisms (1 paper), Analytical Chemistry and Chromatography (1 paper), Scientific Computing and Data Management (1 paper), Clinical Laboratory Practices and Quality Control (1 paper) and Cloud Computing and Resource Management (1 paper). The work is most often cited by research in Ophthalmology (153 citations), Pharmacology (54 citations), Immunology (102 citations), Pharmaceutical Science (35 citations) and Pharmacology (46 citations). Joel Usansky has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include D. Dan-Shya Tang-Liu, Franklin P. Spriggs, Julie A. TerWee, John S. Kenney, Valerie Theobald, Adrienne Clements‐Egan, Afshin Safavi, Denise M. O’Hara, Mauricio Maia and L. A. Damani. Their work appears in journals such as The AAPS Journal, Clinical Pharmacology & Therapeutics, Bioanalysis, Clinical Pharmacokinetics and Survey of Ophthalmology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.